| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6014931
[patent_doc_number] => 20020102231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Therapeutic uses of PAF-AH products in diabetes'
[patent_app_type] => new
[patent_app_number] => 09/774414
[patent_app_country] => US
[patent_app_date] => 2001-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7162
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102231.pdf
[firstpage_image] =>[orig_patent_app_number] => 09774414
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/774414 | Therapeutic uses of PAF-AH products in diabetes | Jan 30, 2001 | Abandoned |
Array
(
[id] => 6062961
[patent_doc_number] => 20020031543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Adjuvant comprising pulmonary surfactant'
[patent_app_type] => new
[patent_app_number] => 09/772768
[patent_app_country] => US
[patent_app_date] => 2001-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6256
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20020031543.pdf
[firstpage_image] =>[orig_patent_app_number] => 09772768
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/772768 | Adjuvant comprising pulmonary surfactant | Jan 29, 2001 | Abandoned |
Array
(
[id] => 6541697
[patent_doc_number] => 20020110558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Use of CD25 binding molecules in the treatment of rheumatoid arthritis or skin diseases'
[patent_app_type] => new
[patent_app_number] => 09/770002
[patent_app_country] => US
[patent_app_date] => 2001-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3567
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20020110558.pdf
[firstpage_image] =>[orig_patent_app_number] => 09770002
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/770002 | Use of CD25 binding molecules in the treatment of rheumatoid arthritis or skin diseases | Jan 24, 2001 | Abandoned |
| 09/700200 | Antibodies to dendritic cells and human dendritic cell populations and uses thereof | Jan 22, 2001 | Abandoned |
Array
(
[id] => 6908051
[patent_doc_number] => 20010010818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-02
[patent_title] => 'Methods and formulations for reducing circulating antibodies'
[patent_app_type] => new
[patent_app_number] => 09/766365
[patent_app_country] => US
[patent_app_date] => 2001-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 16981
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20010010818.pdf
[firstpage_image] =>[orig_patent_app_number] => 09766365
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/766365 | Methods and formulations for reducing circulating antibodies | Jan 17, 2001 | Abandoned |
Array
(
[id] => 6340685
[patent_doc_number] => 20020034507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Inhibitor of lymphocyte activation'
[patent_app_type] => new
[patent_app_number] => 09/760723
[patent_app_country] => US
[patent_app_date] => 2001-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12132
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20020034507.pdf
[firstpage_image] =>[orig_patent_app_number] => 09760723
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/760723 | Inhibitor of lymphocyte activation | Jan 16, 2001 | Abandoned |
| 09/701545 | Groups of genes expressed in human dendritic cells | Jan 10, 2001 | Abandoned |
Array
(
[id] => 6896147
[patent_doc_number] => 20010026937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-04
[patent_title] => 'Monocyte-derived dendritic cell subsets'
[patent_app_type] => new
[patent_app_number] => 09/760388
[patent_app_country] => US
[patent_app_date] => 2001-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 28277
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20010026937.pdf
[firstpage_image] =>[orig_patent_app_number] => 09760388
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/760388 | Monocyte-derived dendritic cell subsets | Jan 9, 2001 | Abandoned |
Array
(
[id] => 1129402
[patent_doc_number] => 06787154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-09-07
[patent_title] => 'Artificial antigen presenting cells'
[patent_app_type] => B2
[patent_app_number] => 09/756983
[patent_app_country] => US
[patent_app_date] => 2001-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 79
[patent_no_of_words] => 42826
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787154.pdf
[firstpage_image] =>[orig_patent_app_number] => 09756983
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/756983 | Artificial antigen presenting cells | Jan 8, 2001 | Issued |
Array
(
[id] => 7118339
[patent_doc_number] => 20010001663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-05-24
[patent_title] => 'Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component'
[patent_app_type] => new-utility
[patent_app_number] => 09/756125
[patent_app_country] => US
[patent_app_date] => 2001-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7641
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20010001663.pdf
[firstpage_image] =>[orig_patent_app_number] => 09756125
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/756125 | Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component | Jan 8, 2001 | Issued |
Array
(
[id] => 6889367
[patent_doc_number] => 20010024822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-27
[patent_title] => 'Method for inducing immunosuppressive cells and a culture device to be used therefor'
[patent_app_type] => new
[patent_app_number] => 09/756214
[patent_app_country] => US
[patent_app_date] => 2001-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6542
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20010024822.pdf
[firstpage_image] =>[orig_patent_app_number] => 09756214
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/756214 | Method for inducing immunosuppressive cells and a culture device to be used therefor | Jan 8, 2001 | Abandoned |
Array
(
[id] => 6624670
[patent_doc_number] => 20020086276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Immunotherapeutic methods for extracorporeal modulation of CD36 and its ligands'
[patent_app_type] => new
[patent_app_number] => 09/750973
[patent_app_country] => US
[patent_app_date] => 2000-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16880
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086276.pdf
[firstpage_image] =>[orig_patent_app_number] => 09750973
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/750973 | Immunotherapeutic methods for extracorporeal modulation of CD36 and its ligands | Dec 27, 2000 | Abandoned |
Array
(
[id] => 6774171
[patent_doc_number] => 20030017509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus'
[patent_app_type] => new
[patent_app_number] => 09/735422
[patent_app_country] => US
[patent_app_date] => 2000-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7944
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017509.pdf
[firstpage_image] =>[orig_patent_app_number] => 09735422
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/735422 | Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus | Dec 11, 2000 | Abandoned |
Array
(
[id] => 6306097
[patent_doc_number] => 20020094545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads'
[patent_app_type] => new
[patent_app_number] => 09/726883
[patent_app_country] => US
[patent_app_date] => 2000-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3657
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094545.pdf
[firstpage_image] =>[orig_patent_app_number] => 09726883
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/726883 | Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads | Nov 29, 2000 | Abandoned |
Array
(
[id] => 7625336
[patent_doc_number] => 06723833
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-20
[patent_title] => 'Therapeutic compositions comprising anti-IGE antibodies and immunosuppressive agent'
[patent_app_type] => B1
[patent_app_number] => 09/716028
[patent_app_country] => US
[patent_app_date] => 2000-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 52821
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723833.pdf
[firstpage_image] =>[orig_patent_app_number] => 09716028
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/716028 | Therapeutic compositions comprising anti-IGE antibodies and immunosuppressive agent | Nov 16, 2000 | Issued |
Array
(
[id] => 741987
[patent_doc_number] => 07030228
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-18
[patent_title] => 'Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby'
[patent_app_type] => utility
[patent_app_number] => 09/714712
[patent_app_country] => US
[patent_app_date] => 2000-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 24
[patent_no_of_words] => 34460
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/030/07030228.pdf
[firstpage_image] =>[orig_patent_app_number] => 09714712
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/714712 | Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby | Nov 14, 2000 | Issued |
| 09/713098 | Mammalian genes; related reagents and methods | Nov 13, 2000 | Abandoned |
Array
(
[id] => 1170413
[patent_doc_number] => 06749852
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-15
[patent_title] => 'Method for preventing and inhibiting human HLA alloimmune response to platelet transfusion'
[patent_app_type] => B1
[patent_app_number] => 09/709249
[patent_app_country] => US
[patent_app_date] => 2000-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4582
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/749/06749852.pdf
[firstpage_image] =>[orig_patent_app_number] => 09709249
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/709249 | Method for preventing and inhibiting human HLA alloimmune response to platelet transfusion | Nov 9, 2000 | Issued |
| 09/710249 | Recombinant gelatins in vaccines | Nov 9, 2000 | Abandoned |
| 09/706301 | Oil adjuvant vaccine | Nov 2, 2000 | Abandoned |